Renal Cancer

Toni Choueiri, MD, Shares Positive Findings in Brain Metastases from RCC
Videos
Toni Choueiri, MD, Shares Positive Findings in Brain Metastases from RCC
02/16/2021
Dr Choueiri talks about results from a retrospective analysis of patients with metastatic RCC and brain metastases.
Dr Choueiri talks about results from a retrospective analysis of patients with metastatic RCC and brain metastases.
Dr Choueiri talks about results...
02/16/2021
Oncology
Dr Choueiri Highlights Nivolumab Plus Cabozantinib vs Sunitinib for Advanced RCC
Videos
Dr Choueiri Highlights Nivolumab Plus Cabozantinib vs Sunitinib for Advanced RCC
02/16/2021
Toni Choueiri, MD, shares results from a new analysis of the phase 3 Checkmate 9ER trial of cabozantinib plus nivolumab for the first-line treatment of advanced RCC.
Toni Choueiri, MD, shares results from a new analysis of the phase 3 Checkmate 9ER trial of cabozantinib plus nivolumab for the first-line treatment of advanced RCC.
Toni Choueiri, MD, shares...
02/16/2021
Oncology
Scott Tykodi, MD, PhD, Discusses Gene Expression Analysis and Mutational Profiling in KEYNOTE-427 Trial for RCC
Videos
Scott Tykodi, MD, PhD, Discusses Gene Expression Analysis and Mutational Profiling in KEYNOTE-427 Trial for RCC
07/10/2020
Dr Tykodi shares data analyses of cohort A from the KEYNOTE-427 trial on first-line pembrolizumab for clear cell renal cell carcinoma, presented in two abstracts at the virtual 2020 ASCO Annual Meeting.
Dr Tykodi shares data analyses of cohort A from the KEYNOTE-427 trial on first-line pembrolizumab for clear cell renal cell carcinoma, presented in two abstracts at the virtual 2020 ASCO Annual Meeting.
Dr Tykodi shares data analyses...
07/10/2020
Oncology
Pembrolizumab Yields Impressive Ongoing Responses in Treatment-Naive RCC
Videos
Pembrolizumab Yields Impressive Ongoing Responses in Treatment-Naive RCC
06/03/2020
David McDermott, MD, discusses the encouraging follow-up findings of the KEYNOTE-427 clinical trial.
David McDermott, MD, discusses the encouraging follow-up findings of the KEYNOTE-427 clinical trial.
David McDermott, MD, discusses...
06/03/2020
Oncology
Podcasts
“Spectacular” Trial Results Establish New Standard of Care for Advanced Kidney Cancer
02/21/2019
Dr Rini discusses the pivotal results of the KEYNOTE-426 trial, which compared the use of axitinib plus pembrolizumab with sunitinib in treatment-naïve patients with advanced kidney cancer.
Dr Rini discusses the pivotal results of the KEYNOTE-426 trial, which compared the use of axitinib plus pembrolizumab with sunitinib in treatment-naïve patients with advanced kidney cancer.
Dr Rini discusses the pivotal...
02/21/2019
Oncology
Podcasts
Tivozanib Shows Promise Over Sorafenib in Patients With Advanced, Treatment-Refractory RCC
02/16/2019
Dr Rini talks about the findings of the TIVO-3 clinical trial, which compared the use of tivozanib with sorafenib in patients with advanced, treatment-refractory RCC.
Dr Rini talks about the findings of the TIVO-3 clinical trial, which compared the use of tivozanib with sorafenib in patients with advanced, treatment-refractory RCC.
Dr Rini talks about the findings...
02/16/2019
Oncology
Podcasts
New Advances in Research Pave the Way for the Treatment of Nonclear Cell RCC
02/14/2019
David F. McDermott, MD, talks about the recent advances in the treatment landscape for patients with nonclear cell renal cell carcinoma.
David F. McDermott, MD, talks about the recent advances in the treatment landscape for patients with nonclear cell renal cell carcinoma.
David F. McDermott, MD, talks...
02/14/2019
Oncology
News
Immunotherapy Trumps TKI in Clear Cell RCC With Altered DDR Genes
02/14/2019
Patients with metastatic clear cell RCC and a loss of function in DNA damage repair (DDR) genes had better survival outcomes when treated with immunotherapy versus TKI therapy, according to study results presented at the 2019 ASCO GI Cancers...
Patients with metastatic clear cell RCC and a loss of function in DNA damage repair (DDR) genes had better survival outcomes when treated with immunotherapy versus TKI therapy, according to study results presented at the 2019 ASCO GI Cancers...
Patients with metastatic clear...
02/14/2019
Oncology

Upcoming Events

Advances in Inflammatory Bowel Disease Regionals
April 5 ⁠–⁠ April 6
Rx summit logo
April 21 ⁠–⁠ April 24
April 29 ⁠–⁠ April 30
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
Psych Congress Regionals
May 1 ⁠–⁠ May 2
May 7 ⁠–⁠ May 9
NEI Congress
May 8 ⁠–⁠ May 10
Dermatology Week
May 14 ⁠–⁠ May 16
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
May 28 ⁠–⁠ May 31
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use